WSJ Opinion. Housing Is Back—But Housing Stocks Are Due

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone wowhappens28 #3873

WSJ Opinion. Housing Is Back—But Housing Stocks Are Due for a Fall

Stock investors seem convinced that housing is headed for another boom. The shares of companies that build homes have rocketed in the past 18 months in anticipation of much better times.

But while signs for the housing market are indeed optimistic, housing stocks have risen too far, too fast. If you want to bet on rising home prices, you probably are better off investing directly in real estate, whether by buying your first home, trading up to a more expensive one or—if the math works—buying a rental property as an investment.

Your correspondent is kicking himself. Eighteen months ago, in the summer of 2011, I saw the housing market turn before my eyes while I was shopping for a condo in the Miami area. The smart move would have been to take leave of my real-estate agent, head for the nearest brokerage house and buy stocks in home-building companies instead.

Since August 2011, the Philadelphia Housing Sector index of U.S. home-building stocks has jumped about 140%, while the Standard & Poor's 500-stock index is up about 30%. U.S. house prices overall have risen by less than 10%.

The case for a housing turnaround—at long last—is strong. Experts say the U.S. needs to build more than 1.5 million new homes every year just to keep up with the creation of new households and to replace old buildings. For the past five years, the average has been 760,000. Last year, it was 650,000.

"We're still building housing at about half the rate that would be considered normal," says Michael Widner, a home-building analyst at investment firm Stifel Nicolaus, which has $136 billion in assets under management. He believes the boom will continue.

The industry has built too few homes recently because it spent years building too many. Most of the excess inventory now is gone, and what remains might not prove a drag on prices anyway. Much of it is in the wrong places: While vacancy rates remain high in Detroit and parts of Nevada and Florida, there are housing shortages elsewhere, such as in Silicon Valley. And some of the "inventory" built up during the bubble is unlivable.

Think of the speculative housing developments in Florida swampland that were never occupied, next to golf courses that never got built. In total, U.S. home construction over the past decade, encompassing both the boom and the aftermath, has averaged just 1.3 million units a year, below the rate needed.

There are other signs that the housing glut is at an end. According to U.S. Census data, the percentage of homes unoccupied is back down to where it was before the financial crisis. Rents nationwide have been edging up.

After five years of falling prices, housing is now inexpensive by several key measures. The Standard & Poor's/Case-Shiller national home-price index is back to 2003 levels. When compared with average wages, prices are at levels seen in the mid-1990s, long before the boom.

Most people buy homes with a mortgage, and rates for those have plummeted to record lows. A 30-year fixed-rate conventional mortgage is now 3.5% or less. All this makes housing cheap for people with jobs.

To be sure, plenty of risks remain. Economists note that U.S. unemployment remains stubbornly high. No matter how cheap houses might be, families won't be able to afford them without income.

If the housing market continues to recover, home-building companies should see strong profits, says Crispin Odey, chairman of $12 billion hedge fund firm Odey & Co. in London. Their operating profits will widen, their land holdings will rise in value, and they will sell their new homes much more quickly, saving on capital costs, he argues.

Mr. Odey is an investor in home builders PulteGroup , PHM +3.29% D.R. Horton DHI +0.18% and KB Home , KBH +1.42% and says the sector could continue to see substantial gains.

Yet investors should be cautious. At current levels, say analysts, home-building stocks have priced in much of the recovery ahead.

As the chart shows, the Philadelphia Stock Exchange Housing Sector Index has rebounded far more significantly than housing itself. Shares of D.R. Horton now trade at 1.9 times the per-share value of the company's net assets, approaching the 2.3 level seen in 2004-05. During the crash it sank as low as 0.6 times assets. PulteGroup has swelled to 3.7 times its per-share net assets, a record.

Those asset values have been depressed by the slump and will be revalued upward if house prices continue to recover.

Yet Stifel's Mr. Widner says the recovery "is already baked into prices." Even though expects the housing market to recover steadily over the next few years, he rates the stocks no better than a "hold" across the board.

For the average investor, housing surely offers a better bet than housing stocks. Prices are lower, and investors can benefit from leverage through a mortgage, putting down just 20% in cash for the chance to enjoy 100% of any later profits.

Sure, leverage was a disaster at the peak of the bubble, as investors were buying overpriced housing, often with risky flexible-rate loans. But buying inexpensive housing, with a low-cost, fixed-rate mortgage, offers a different balance of risks.

Real estate, famously, is about location, location, location. Each market is different. In some it is still cheaper to rent than to own. But in most of the country, real estate is now inexpensive. This is a good time to buy a first home, to trade up, or to buy a property as an investment.

At this point in the real-estate recovery, homes look like a much better investment than home-building stocks.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 279

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 235

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 757

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 293

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 930

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading

Top 5 Most Recently Viewed Articles

Avacta Therapeutics Showcases Promising FAP-Dox Data at ESMO

Updated Category News Views 196

Avacta Therapeutics Presents FAP-Dox Data at International Congress Avacta Therapeutics, a pioneering life sciences company, is set to present an exciting update regarding their innovative drug FAP-Dox (AVA6000) at an esteemed international oncology congress. This event will spotlight groundbreaking research and clinical advancements in targeted cancer treatments that can...

Continue Reading
Qvinci and Harmonyze Join Forces to Revolutionize Franchise Coaching

Updated Category News Views 163

Strategic Collaboration Between Qvinci and Harmonyze In a remarkable development, Qvinci Software, renowned for its innovative franchise financial performance solutions, has announced a pivotal partnership with Harmonyze, an AI-driven performance coaching platform. This collaboration is designed to assist franchisors in transforming intricate financial insights into...

Continue Reading
Citi Remains Optimistic on Capgemini Amid Margin Growth

Updated Category News Views 198

Outlook for Capgemini Stock Citi analyst Balajee Tirupati has recently made adjustments to the price target for Capgemini SE (CAP:FP) (OTC: CAPMF), reducing it to €215 from €225. Despite this revision, Citi has maintained a positive stance, continuing to endorse a Buy rating for Capgemini's stock. Weaker Third-Quarter Update Capgemini's recent third-quarter report for...

Continue Reading
Beyond Oil Marks Key Milestone with Initial Shipment to T&J Oil

Updated Category News Views 252

Beyond Oil's Successful Expansion into the Australian Market Following its commitment to health and sustainability, Beyond Oil Ltd. (CSE: BOIL, OTCQB: BEOLF) has successfully delivered its first shipment of 5.4 tonnes of proprietary oil treatment products to T&J Oil Pty Ltd. This marks an important leap for the company as it steps into the Australian distribution arena,...

Continue Reading
Donaldson Partners with the Special Olympics to Inspire Change

Updated Category News Views 87

Donaldson's Commitment to Community Engagement Donaldson Company, Inc. (NYSE: DCI), a leader in innovative filtration solutions, has taken a significant step towards community engagement by announcing its partnership with the 2026 Special Olympics USA Games. This event is set to create a platform for inclusion, offering athletes with diverse abilities an opportunity to...

Continue Reading